Developmental stage and cellular context determine oncogenic and molecular outcomes of Ezh2Y641F mutation in hematopoiesis
Abstract: Mutations in the histone methyltransferase enhancer of zeste homolog 2 (EZH2), particularly the neomorphic Y641F hot spot mutation, are implicated in hematologic malignancies. However, how developmental timing and cellular context influence their oncogenic potential remains poorly understo...
Saved in:
| Main Authors: | Sarah M. Zimmerman, Samantha J. Procasky, Sofia R. Smith, Jie-Yu Liu, Chad Torrice, George P. Souroullas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S295032802500072X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma
by: Aránzazu Chamorro-Jorganes, et al.
Published: (2025-03-01) -
Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities
by: Michal Wozniak, et al.
Published: (2025-01-01) -
Deep Tissue Sculpture in Neck Rejuvenation: Review of 641 Consecutive Cases
by: Samir M. Ghoraba, MD, MRCS
Published: (2024-12-01) -
EZH2 mutations increase the heterogeneity of chromatin states in lymphoma
by: Daniel Holoch, et al.
Published: (2025-06-01) -
EZH2 mutations increase the heterogeneity of chromatin states in lymphoma.
by: Daniel Holoch, et al.
Published: (2025-06-01)